BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37474506)

  • 1. Computational analysis of peripheral blood smears detects disease-associated cytomorphologies.
    de Almeida JG; Gudgin E; Besser M; Dunn WG; Cooper J; Haferlach T; Vassiliou GS; Gerstung M
    Nat Commun; 2023 Jul; 14(1):4378. PubMed ID: 37474506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysplasia features of myelodysplastic syndrome in ethnically Chinese people.
    Xiong B; Tang ZH; Zou P; Yue QF; Chen WX; Liu XY
    Acta Haematol; 2014; 131(2):126-32. PubMed ID: 24158033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinically relevant possibilities and limits of differential diagnosis of megaloblastic anemia and myelodysplastic syndrome - refractory anemia type in bone marrow biopsies].
    Vašeková P; Szépe P; Marcinek J; Balhárek T; Plank L
    Vnitr Lek; 2016; 62(9):692-697. PubMed ID: 27715070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of Myelodysplastic Syndrome in Patients Evaluated for Cytopenia(s). A Report from a Reference Centre in Saudi Arabia.
    AlMozain N; Mashi A; Alneami Q; Al-Omran A; Bakshi N; Owaidah T; Khalil S; Khogeer H; Hashmi S; Al-Sweedan S; Morris T; AlNounou R
    Hematol Oncol Stem Cell Ther; 2022 Jun; 15(2):39-44. PubMed ID: 33227261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology.
    Bastida JM; López-Godino O; Vicente-Sánchez A; Bonanad-Boix S; Xicoy-Cirici B; Hernández-Sánchez JM; Such E; Cervera J; Caballero-Berrocal JC; López-Cadenas F; Arnao-Herráiz M; Rodríguez I; Llopis-Calatayud I; Jiménez MJ; Del Cañizo-Roldán MC; Díez-Campelo M
    Int J Lab Hematol; 2019 Feb; 41(1):109-117. PubMed ID: 30290085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.
    Malcovati L; Stevenson K; Papaemmanuil E; Neuberg D; Bejar R; Boultwood J; Bowen DT; Campbell PJ; Ebert BL; Fenaux P; Haferlach T; Heuser M; Jansen JH; Komrokji RS; Maciejewski JP; Walter MJ; Fontenay M; Garcia-Manero G; Graubert TA; Karsan A; Meggendorfer M; Pellagatti A; Sallman DA; Savona MR; Sekeres MA; Steensma DP; Tauro S; Thol F; Vyas P; Van de Loosdrecht AA; Haase D; Tüchler H; Greenberg PL; Ogawa S; Hellstrom-Lindberg E; Cazzola M
    Blood; 2020 Jul; 136(2):157-170. PubMed ID: 32347921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts.
    Adema V; Ma F; Kanagal-Shamanna R; Thongon N; Montalban-Bravo G; Yang H; Peslak SA; Wang F; Acha P; Sole F; Lockyer P; Cassari M; Maciejewski JP; Visconte V; Gañán-Gómez I; Song Y; Bueso-Ramos C; Pellegrini M; Tan TM; Bejar R; Carew JS; Halene S; Santini V; Al-Atrash G; Clise-Dwyer K; Garcia-Manero G; Blobel GA; Colla S
    Blood Cancer Discov; 2022 Nov; 3(6):554-567. PubMed ID: 35926182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemogram and bone marrow morphology in children with chronic aplastic anemia and myelodysplastic syndrome.
    Wen JQ; Feng HL; Wang XQ; Pang JP
    World J Pediatr; 2008 Feb; 4(1):36-40. PubMed ID: 18402250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes.
    Lieu YK; Liu Z; Ali AM; Wei X; Penson A; Zhang J; An X; Rabadan R; Raza A; Manley JL; Mukherjee S
    Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34930825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxysmal nocturnal hemoglobinuria testing in patients with myelodysplastic syndrome in clinical practice-frequency and indications.
    Wong SA; Dalal BI; Leitch HA
    Curr Oncol; 2018 Oct; 25(5):e391-e397. PubMed ID: 30464689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classification and clinical findings of myelodysplastic syndromes].
    Tsuruda K; Hasegawa H; Fuchigami M; Uno N; Morinaga Y; Miyazaki Y; Yanagihara K
    Rinsho Byori; 2014 Apr; 62(4):359-68. PubMed ID: 25022065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD36 relative mean fluorescence intensity of CD105
    Lu Y; Chen X; Zhang L
    Sci Rep; 2023 Jun; 13(1):8930. PubMed ID: 37264109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of bone marrow and blood cell morphology between refractory anemia and other anemia disease].
    Cheng H; Jiang M; DU W; Zhong D; Hao JP; Li L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1423-6. PubMed ID: 23257446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A feature of hematological findings in myelodysplastic syndromes].
    Bando S; Niiya T; Murase M; Makino H
    Rinsho Byori; 1998 Aug; 46(8):790-5. PubMed ID: 9760831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
    Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
    Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
    Garcia-Manero G
    Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the routine CBC: machine learning and statistical analyses identify research CBC parameter associations with myelodysplastic syndromes and specific underlying pathogenic variants.
    Pozdnyakova O; Niculescu RS; Kroll T; Golemme L; Raymond N; Briggs D; Kim A
    J Clin Pathol; 2023 Sep; 76(9):624-631. PubMed ID: 35577566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
    Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
    Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.